SUBSCRIBE
SUBSCRIBE

Novo Nordisk A/S Increased Operating Profit In Local Currencies By 15% In The First Quarter Of 2014

May 1, 2014 | 
1 min read

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

BAGSVAERD, Denmark, May 1, 2014 (GLOBE NEWSWIRE) -- 7% sales growth in local currencies driven by Levemir® and Victoza®.

Help employers find you! Check out all the jobs and post your resume.

Europe
Novo Nordisk
MORE ON THIS TOPIC
Contemporary art collage showing a hand giving a thumbs down surrounded by red arrows pointing down, concept of negative feedback and bad review
Regulatory
Biogen, Eisai’s Leqembi Suffers Overseas Setbacks as UK Denies Coverage, Australia Denies Approval
March 7, 2025
 · 
2 min read
 · 
Tristan Manalac
The EMA's former headquarters in London
Europe
Biogen, Eisai Continue Leqembi’s European Rally as CHMP Reaffirms Positive Opinion
March 3, 2025
 · 
2 min read
 · 
Tristan Manalac
Weigh scales on pink background, top view with space for text. Overweight concept
Obesity
UK Pharmacies Regulator Wants Tighter Checks on Weight Loss Injections
February 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Government
Trump’s Tariffs Threaten Big Pharma With Higher Costs and Slimmer Margins
February 3, 2025
 · 
3 min read
 · 
Tristan Manalac